The impact of social isolation on aging health in schizophrenia
The impact of social isolation on aging health in schizophrenia
批准号:
10522303
负责人:
ABRAHAM REICHENBERG
金额:
$76.41万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2027-05-31
关键词:
AgeAge-YearsAgingAntipsychotic AgentsBehaviorBiological MarkersBody mass indexCOVID-19COVID-19 pandemicCharacteristicsClinicalCognitionCountryDataDepressed moodDiagnosisDietDiseaseEthnic OriginEthnic groupEuropeExhibitsGeneral PopulationGoalsGovernmentHealthIndividualInstitutesLifeLonelinessLongevityMeasuresMedicalMedical RecordsMental DepressionNatural experimentOutcomeParticipantPatientsPatternPhenotypePhysiciansPremature MortalityPreventiveProcessPsychotic DisordersRaceResearchResourcesRiskRisk FactorsSchizophreniaSeverity of illnessSiblingsSmokeSmokingSocial NetworkSocial isolationSocializationStressSubgroupSymptomsTestingTimeUnhealthy DietVulnerable PopulationsWorkage relatedcohortcomorbiditycoronavirus diseasedesigndigitalfollow-uphealth datahealth differencehuman old age (65+)longitudinal databaselongitudinal designmiddle agemortalityneuropsychiatrypandemic diseasephysical conditioningphysical inactivityprematurepreventracial and ethnicsecondary analysissexsocial contactsymptomatologytargeted treatmentunhealthy lifestyle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk
of premature mortality, with a 10–20-year shorter lifespan relative to the general population. Increased mortality
rates in SZ are largely attributable to the early manifestation of medical conditions that normally occur later in
life, a process known as ‘accelerated aging’. While unhealthy lifestyle behaviors, such as smoking and unhealthy
diet, account, in part, for accelerated aging in SZ, the excess of physical comorbidities cannot be solely attributed
to these factors. Remarkably, the direct adverse health effects of key clinical characteristics of SZ have rarely
been considered. In the general population, the absence of social contact is known to pose enormous challenges
for physical health, especially at older ages. Given that social isolation is a persistent and disabling feature of
SZ, it is possible that this behavior may contribute to the premature manifestation of health conditions in SZ.
Building on rich pilot data pointing to significant associations between social isolation and long-term perceived
health in SZ, our overarching goal is to test whether and how social isolation contributes to the health
challenges of individuals with SZ as they age. With participants from Europe (EU-GEI) and the US (Olin
Neuropsychiatry Research Center), we will create a longitudinal database of 650 participants, including 500
individuals with SZ, and 150 of their unaffected siblings. We will apply an accelerated longitudinal design by re-
assessing and by examining medical records of research participants who were first evaluated between the
ages of 30-50 and are now 50-65 years of age, a period when many medical conditions and health problems
tend to manifest. We will determine the age-related association between social isolation and adverse health
outcomes in SZ, test for familiality, directionality, and factors moderating this association, and determine the
extent to which the COVID-19 pandemic and the resulting imposed lockdowns impacted health in SZ. We will
consider generalizability across countries, sexes, and race/ethnicities. The rationale for the proposed research
is that in order to facilitate much-needed targeted therapies to prevent early mortality in SZ, we need to better
understand factors that contribute to the excess of medical comorbidities in SZ. Our central hypothesis is that
social isolation, a common and persistent characteristic of SZ, contributes to the excess of physical
comorbidities in SZ. To meet our overall goal, we will pursue the following aims: (1) Determine the association
between social isolation and adverse health outcomes in SZ; (2) Test for the directionality, and moderating
factors, of the association between social isolation and health outcomes in SZ, and; (3) Examine whether the
COVID-19 pandemic modified associations between social isolation and health outcome in SZ. This study will
be the first to comprehensively examine the health impact of social isolation in SZ. The project may show that
in SZ socialization in midlife can reduce the risk for poor health outcomes and ultimately facilitate much-needed
preventive targeted therapies to reduce early-age mortality in SZ.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of social isolation on aging health in schizophrenia
-
批准号:10680522
-
项目类别:
-
资助金额:$64.44万
-
财政年份:2022
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism and Prenatal Endocrine Disruptors (A-PED)
-
批准号:10251532
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2021
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
-
批准号:10674627
-
项目类别:
-
资助金额:$65.63万
-
财政年份:2019
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
-
批准号:10443600
-
项目类别:
-
资助金额:$66.03万
-
财政年份:2019
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
-
批准号:10178066
-
项目类别:
-
资助金额:$65.17万
-
财政年份:2019
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism and Prenatal Endocrine Disruptors (A-PED)
-
批准号:9349499
-
项目类别:
-
资助金额:$60.63万
-
财政年份:2016
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism and Prenatal Endocrine Disruptors (A-PED)
-
批准号:9133065
-
项目类别:
-
资助金额:$63.08万
-
财政年份:2016
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Autism and Prenatal Endocrine Disruptors (A-PED)
-
批准号:10006730
-
项目类别:
-
资助金额:$57.99万
-
财政年份:2016
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Multigenerational FamIlial and Environmental Risk for Autism (MINERvA) Network
-
批准号:9121391
-
项目类别:
-
资助金额:$98.99万
-
财政年份:2012
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Multigenerational FamIlial and Environmental Risk for Autism (MINERvA) Network
-
批准号:8537788
-
项目类别:
-
资助金额:$94.84万
-
财政年份:2012
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
Multigenerational FamIlial and Environmental Risk for Autism (MINERvA) Network
-
批准号:8386420
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2012
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
EXPLORING THE MECHANISMS OF SUPERIOR COGNITIVE PERFORMANCE IN SCHIZOPHRENIA
-
批准号:7718181
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2008
-
负责人:ABRAHAM REICHENBERG
-
依托单位:
海外基金